Curaleaf Holdings (CURLF) FCF Margin (2019 - 2024)
Curaleaf Holdings (CURLF) recorded quarterly FCF Margin of 34.07% in Q4 2024, down 260.49% quarter-over-quarter from 21.23% in Q3 2024, and up 1095331.0% on a YoY basis from N/an in Q1 2024.
Curaleaf Holdings (CURLF) FCF Margin (2019 - 2024) Analysis & Trends
Curaleaf Holdings' FCF Margin history runs 6 years deep, the most recent figure standing at 34.07% for Q4 2024.
- In Q4 2024, FCF Margin rose 1095331.0% year-over-year to 34.07%; the TTM figure through Sep 2025 stood at 11.57% (down 2198.0% YoY), while the FY2025 annual figure was 10.64%, up 531.0% from the prior year.
- FCF Margin was 34.07% for Q4 2024 at Curaleaf Holdings, down from 21.23% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 12915.87% in Q1 2024 to a low of 12767.93% in Q2 2024.
- Historically, FCF Margin has averaged 699.64% across 5 years, with a median of 2.12% in 2020.
- The sharpest annual moves came in 2023 and 2024: FCF Margin slumped 1092261 bps in 2023, then jumped 1095331 bps in 2024.
- A 5-year view of FCF Margin shows it stood at 77.0% in 2020, then surged by 110 bps to 7.71% in 2021, then slumped by 940 bps to 64.77% in 2022, then tumbled by 16865 bps to 10987.38% in 2023, then soared by 100 bps to 34.07% in 2024.
- The last three FCF Margin figures came in at 34.07% (Q4 2024), 21.23% (Q3 2024), and 12767.93% (Q2 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | -5.22% |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 12.86% |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 46.39% |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 16.78% |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | -2.77% |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -429.96% |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 32.62% |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 13.24% |
| 10 | Curaleaf Holdings | - | - | 157.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -34.07% |
| Sep 30, 2024 | 21.23% |
| Jun 30, 2024 | -12,767.93% |
| Mar 31, 2024 | 12,915.87% |
| Dec 31, 2023 | -10,987.38% |
| Sep 30, 2023 | 18.66% |
| Jun 30, 2023 | -2,348.75% |
| Dec 31, 2022 | -64.77% |
| Sep 30, 2022 | 13.55% |
| Jun 30, 2022 | -20.61% |
| Mar 31, 2022 | 18.42% |
| Dec 31, 2021 | 7.71% |
| Sep 30, 2021 | 16.40% |
| Jun 30, 2021 | -23.55% |
| Mar 31, 2021 | -2.30% |
| Dec 31, 2020 | -77.00% |
| Sep 30, 2020 | -0.02% |
| Jun 30, 2020 | 23.55% |
| Mar 31, 2020 | -2.12% |
| Dec 31, 2019 | -289.58% |